CAZZANIGA, MARINA ELENA
CAZZANIGA, MARINA ELENA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract
1993 Lissoni, P; Barni, S; Tancini, G; Ardizzoia, A; Rovelli, F; Cazzaniga, M; Brivio, F; Piperno, A; Aldeghi, R; Fossati, D; Characiejus, D; Kothari, L; Conti, A; Maestroni, G
Bisphosphonates and metastatic bone disease
2006 Barni, S; Mandalà, M; Cazzaniga, M; Cabiddu, M; Cremonesi, M
Adjuvant systemic treatment of early breast cancer: the NORA study
2006 Cazzaniga, M; Mustacchi, G; Pronzato, P; De Matteis, A; Di Costanzo, F; Floriani, I
The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma
2006 Mandalà, M; Falanga, A; Cremonesi, M; Zaccanelli, M; Floriani, I; Viganò, M; Rosti, A; Cazzaniga, M; Ferretti, G; Cabiddu, M; Barni, S
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study
2007 Cazzaniga, M; Mustacchi, G; Pronzato, P; De Matteis, A; Di Costanzo, F; Floriani, I; NORA Study, G
Breast cancer in elderly women: a different reality? Results from the NORA study
2007 Mustacchi, G; Cazzaniga, M; Pronzato, P; De Matteis, A; Di Costanzo, F; Floriani, I
From the trastuzumab era to new target therapies: beyond revolution
2007 Barni, S; Petrelli, F; Cabiddu, M; Cazzaniga, M; Cremonesi, M
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study
2007 Barni, S; Visini, M; Piazza, E; Ionta, M; Ardizzoia, A; Arnoldi, E; Fava, S; Pinotti, G; Torretta, F; Corradini, G; Villa, S; Nosenzo, A; Massidda, B; Cazzaniga, M
Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study
2007 Cazzaniga, M; Dogliotti, L; Cascinu, S; Barni, S; Labianca, R; Chiara, S; Conte, P; Gasparini, G; Pasetto, L; Torri, V
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) [Trattamento con Gefitinib nei pazienti anziani o con scarso performance status (PS), affetti da carcinoma polmonare non a piccole cellule (NSCLC)]
2008 Ardizzoia, A; Arnoffi, J; Colombo, I; Villa, F; Dapretto, E; Frontini, L; Lissoni, P; Vaghi, M; Cazzaniga, M; Vigano, I; Gardani, G; Bidoli, P
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC)
2008 Ardizzoia, A; Arnoffi, J; Colombo, I; Villa, F; Dapretto, E; Frontini, L; Lissoni, P; Vaghi, M; Cazzaniga, M; Vigano, I; Gardani, G; Bidoli, P
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study
2008 Cazzaniga, M; Pronzato, P; Mustacchi, G; De Matteis, A; Di Costanzo, F; Rulli, E; Floriani, I
Targeted therapies for the treatment of breast cancer in the post-trastuzumab era
2008 Petrelli, F; Cabiddu, M; Cazzaniga, M; Cremonesi, M; Barni, S
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study
2009 Mustacchi, G; Mansutti, M; Sacco, C; Barni, S; Farris, A; Cazzaniga, M; Cozzi, M; Dellach, C
Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer
2010 Bidoli, P; Cortinovis, D; Colombo, I; Crippa, A; Cicchiello, F; Villa, F; Cazzaniga, M; Altomare, G
Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA study
2011 Pronzato, P; Mustacchi, G; De Matteis, A; Di Costanzo, F; Rulli, E; Floriani, I; Cazzaniga, M
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose
2012 Alberti, P; Cortinovis, D; Cazzaniga, M; Bidoli, P; Cavaletti, G
When progressive dysphagia could be related to an “old friend” – a case report
2012 Alberti, P; Fumagalli, L; Piatti, M; Santoro, P; Pettinaroli, R; Cortinovis, D; Cazzaniga, M; Bidoli, P; Ferrarese, C
Major issue in chemotherapy-induced peripheral neuropathy (cipn): lack of standardized measurement scales. ciperinoms study: validity and reliability in cipn assessment
2012 Cortinovis, D; Cazzaniga, M; Cavaletti, G; Giuntini, N; Canova, S; Alberti, P; Bidoli, P; CI Perinoms Study, G
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study.
2012 Andreas, A; Alberti, P; Briani, C; Velasco, R; Bruna, J; Campagnolo, M; Cazzaniga, M; Bergamo, F; Cortinovis, D; Santos, C; Papadimitriou, K; Cavaletti, G; Kalofonos, H